Literature DB >> 23958793

The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men.

E Konings1, S Timmers2, M V Boekschoten3, G H Goossens1, J W Jocken1, L A Afman3, M Müller3, P Schrauwen2, E C Mariman1, E E Blaak1.   

Abstract

Polyphenolic compounds, such as resveratrol, have recently received widespread interest because of their ability to mimic effects of calorie restriction. The objective of the present study was to gain more insight into the effects of 30 days resveratrol supplementation on adipose tissue morphology and underlying processes. Eleven healthy obese men were supplemented with placebo and resveratrol for 30 days (150 mg per day), separated by a 4-week washout period in a double-blind randomized crossover design. A postprandial abdominal subcutaneous adipose tissue biopsy was collected to assess adipose tissue morphology and gene expression using microarray analysis. Resveratrol significantly decreased adipocyte size, with a shift toward a reduction in the proportion of large and very-large adipocytes and an increase in small adipocytes. Microarray analysis revealed downregulation of Wnt and Notch signaling pathways and upregulation of pathways involved in cell cycle regulation after resveratrol supplementation, suggesting enhanced adipogenesis. Furthermore, lysosomal/phagosomal pathway and transcription factor EB were upregulated reflecting an alternative pathway of lipid breakdown by autophagy. Further research is necessary to investigate whether resveratrol improves adipose tissue function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23958793     DOI: 10.1038/ijo.2013.155

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  20 in total

1.  Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes.

Authors:  E Bråkenhielm; R Cao; Y Cao
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

2.  Adipose tissue secretion and expression of adipocyte-produced and stromavascular fraction-produced adipokines vary during multiple phases of weight-reducing dietary intervention in obese women.

Authors:  Michaela Siklova-Vitkova; Eva Klimcakova; Jan Polak; Zuzana Kovacova; Michaela Tencerova; Lenka Rossmeislova; Magda Bajzova; Dominique Langin; Vladimir Stich
Journal:  J Clin Endocrinol Metab       Date:  2012-04-24       Impact factor: 5.958

3.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

4.  Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner.

Authors:  Pamela Fischer-Posovszky; Vera Kukulus; Daniel Tews; Thomas Unterkircher; Klaus-Michael Debatin; Simone Fulda; Martin Wabitsch
Journal:  Am J Clin Nutr       Date:  2010-05-12       Impact factor: 7.045

5.  Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis.

Authors:  C Garcés; M J Ruiz-Hidalgo; J Font de Mora; C Park; L Miele; J Goldstein; E Bonvini; A Porrás; J Laborda
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

Review 6.  The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance.

Authors:  Gijs H Goossens
Journal:  Physiol Behav       Date:  2007-10-22

7.  Autophagy regulates adipose mass and differentiation in mice.

Authors:  Rajat Singh; Youqing Xiang; Yongjun Wang; Kiran Baikati; Ana Maria Cuervo; Yen K Luu; Yan Tang; Jeffrey E Pessin; Gary J Schwartz; Mark J Czaja
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

8.  Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.

Authors:  Jun Yoshino; Caterina Conte; Luigi Fontana; Bettina Mittendorfer; Shin-ichiro Imai; Kenneth B Schechtman; Charles Gu; Iris Kunz; Filippo Rossi Fanelli; Bruce W Patterson; Samuel Klein
Journal:  Cell Metab       Date:  2012-10-25       Impact factor: 27.287

9.  Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis.

Authors:  T McLaughlin; A Sherman; P Tsao; O Gonzalez; G Yee; C Lamendola; G M Reaven; S W Cushman
Journal:  Diabetologia       Date:  2007-06-05       Impact factor: 10.122

10.  Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.

Authors:  Silvie Timmers; Ellen Konings; Lena Bilet; Riekelt H Houtkooper; Tineke van de Weijer; Gijs H Goossens; Joris Hoeks; Sophie van der Krieken; Dongryeol Ryu; Sander Kersten; Esther Moonen-Kornips; Matthijs K C Hesselink; Iris Kunz; Vera B Schrauwen-Hinderling; Ellen Blaak; Johan Auwerx; Patrick Schrauwen
Journal:  Cell Metab       Date:  2011-11-02       Impact factor: 27.287

View more
  52 in total

1.  White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function.

Authors:  Youn Wook Chung; Faiyaz Ahmad; Yan Tang; Steven C Hockman; Hyun Jung Kee; Karin Berger; Emilia Guirguis; Young Hun Choi; Dan M Schimel; Angel M Aponte; Sunhee Park; Eva Degerman; Vincent C Manganiello
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

Review 2.  Resveratrol supplementation: Where are we now and where should we go?

Authors:  Marta G Novelle; Devin Wahl; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2015-01-24       Impact factor: 10.895

Review 3.  Anti-obesity effects of resveratrol: comparison between animal models and humans.

Authors:  Alfredo Fernández-Quintela; Christian Carpéné; Maialen Fernández; Leixuri Aguirre; Iñaki Milton-Laskibar; José Contreras; Maria P Portillo
Journal:  J Physiol Biochem       Date:  2016-12-15       Impact factor: 4.158

4.  Prevention of obesity by dietary resveratrol: how strong is the evidence?

Authors:  Songbo Wang; Mei-Jun Zhu; Min Du
Journal:  Expert Rev Endocrinol Metab       Date:  2015-10-10

5.  Resveratrol enhances brown adipocyte formation and function by activating AMP-activated protein kinase (AMPK) α1 in mice fed high-fat diet.

Authors:  Songbo Wang; Xingwei Liang; Qiyuan Yang; Xing Fu; Meijun Zhu; B D Rodgers; Qingyan Jiang; Michael V Dodson; Min Du
Journal:  Mol Nutr Food Res       Date:  2017-01-03       Impact factor: 5.914

6.  Nutrigenomic Information in the openEHR Data Set.

Authors:  Priscila Alves Maranhão; Gustavo Marísio Bacelar-Silva; Duarte Nuno Gonçalves Ferreira; Conceição Calhau; Pedro Vieira-Marques; Ricardo João Cruz-Correia
Journal:  Appl Clin Inform       Date:  2018-03-28       Impact factor: 2.342

7.  Physiologically achievable doses of resveratrol enhance 3T3-L1 adipocyte differentiation.

Authors:  Pan Hu; Ling Zhao; Jiangang Chen
Journal:  Eur J Nutr       Date:  2014-07-17       Impact factor: 5.614

Review 8.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

9.  Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.

Authors:  E Hijona; L Aguirre; P Pérez-Matute; M J Villanueva-Millán; A Mosqueda-Solis; M Hasnaoui; F Nepveu; J M Senard; L Bujanda; L Aldámiz-Echevarría; M Llarena; F Andrade; P Perio; F Leboulanger; L Hijona; J M Arbones-Mainar; M P Portillo; C Carpéné
Journal:  J Physiol Biochem       Date:  2016-01-20       Impact factor: 4.158

10.  Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer.

Authors:  Emily L Rossi; Subreen A Khatib; Steven S Doerstling; Laura W Bowers; Melissa Pruski; Nikki A Ford; Randolph D Glickman; Mengmeng Niu; Peiying Yang; Zhengrong Cui; John DiGiovanni; Stephen D Hursting
Journal:  Mol Carcinog       Date:  2017-12-01       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.